Ausgabe 1/2024
Inhalt (8 Artikel)
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
Martina Catalano, Andrea Lapucci, Stefania Nobili, Irene De Gennaro Aquino, Ismaela Anna Vascotto, Lorenzo Antonuzzo, Donata Villari, Gabriella Nesi, Enrico Mini, Giandomenico Roviello
TMEM120A-mediated regulation of chemotherapy sensitivity in colorectal cancer cells
Li Wang, Xiaoxia Liu
A phase I study of the ceramide nanoliposome in patients with advanced solid tumors
Aaron Ciner, Theodore Gourdin, Jeff Davidson, Mylisa Parette, Susan J. Walker, Todd E. Fox, Yixing Jiang
Correlation analysis between camrelizumab trough concentration levels and efficacy or safety in East Asian patients with advanced lung cancer
Mengfei Cheng, Fang Yang, Yanchao Yang, Xinyue Gao, Yang Yu, Nan Wang, Xinyu Luo, Shuo Zhang, Shuai Jiang, Mei Dong
Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells
Man-Yuan Li, Jiao Zhang, Xiao Lu, Dong Zhou, Xu-Feng Deng, Quan-Xing Liu, Ji-Gang Dai, Hong Zheng
Sodium orthovanadate exhibits anti-angiogenic, antiapoptotic and blood glucose-lowering effect on colon cancer associated with diabetes
Kruti Patel, Vivek Bora, Bhoomika Patel
Predictive significance of inflammatory markers and mGPS in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide
Sabin Goktas Aydin, Yasin Kutlu, Harun Muglu, Ahmet Aydin, Ozgur Acikgoz, Jamshid Hamdard, Ebru Karci, Ahmet Bilici, Omer Fatih Olmez, Ozcan Yildiz
Bidirectional pharmacokinetic drug interactions between olaparib and metformin
Joanna Stanisławiak-Rudowicz, Agnieszka Karbownik, Danuta Szkutnik-Fiedler, Filip Otto, Tomasz Grabowski, Anna Wolc, Edmund Grześkowiak, Edyta Szałek